The vaccine work was began in 2018-2019 by collaborative efforts between researchers from IIT-G’s Department of Biosciences and Bioengineering and the Assam Agricultural University in Guwahati.
| Photo Credit: iitg.ac.in
GUWAHATI The Indian Institute of Technology-Guwahati (IIT-G) has transferred a first-of-its-kind vaccine expertise to BioMed Pvt. Ltd., a producing firm specialising in vaccines.
This expertise entails a recombinant vector vaccine designed particularly for combating the classical swine fever virus in pigs and wild boars, filling a big hole in India’s vaccine panorama. This vaccine harnesses a reverse genetic platform pioneered and refined at IIT-G, a press release from the institute stated on March 26.
A extremely contagious illness amongst pigs, swine fever poses a extreme menace with a really excessive mortality fee, though it doesn’t have an effect on people. In India, cases of this illness have been continuously noticed within the northeastern States, in addition to in Bihar, Kerala, Punjab, Haryana, and Gujarat.
The vaccine work was began in 2018-2019 by collaborative efforts between researchers from IIT-G’s Department of Biosciences and Bioengineering and the Assam Agricultural University in Guwahati. Their analysis findings have been revealed in two journals – Process Biochemistry and Archives of Virology.
“Swine fever poses a threat to India’s pig industry as no vaccine is currently available. Transferring the vaccine technology to one of the leaders in the veterinary vaccine sector marks a remarkable achievement,” an IIT-G spokesperson stated.
